Lilly is doubling down on diabetes. Manufacturing President Maria Crowe talks about plans for a $72 million investment in Indianapolis and weighs-in on what the future holds for animal health unit Elanco.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}